Consistent with this assumption, regulatory T cells (Tregs) in MS patients seem to exhibit impaired suppressive activity and abnormally secrete interferon gamma (IFNγ) (Dominguez-Villar et al., 2011). Here, IFNG is linked to myeloid sarcoma.